These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34560142)

  • 1. Visual short-term memory impairments in presymptomatic familial Alzheimer's disease: A longitudinal observational study.
    Pavisic IM; Nicholas JM; Pertzov Y; O'Connor A; Liang Y; Collins JD; Lu K; Weston PSJ; Ryan NS; Husain M; Fox NC; Crutch SJ
    Neuropsychologia; 2021 Nov; 162():108028. PubMed ID: 34560142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eye-tracking indices of impaired encoding of visual short-term memory in familial Alzheimer's disease.
    Pavisic IM; Pertzov Y; Nicholas JM; O'Connor A; Lu K; Yong KXX; Husain M; Fox NC; Crutch SJ
    Sci Rep; 2021 Apr; 11(1):8696. PubMed ID: 33888739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study.
    Weston PSJ; Nicholas JM; Henley SMD; Liang Y; Macpherson K; Donnachie E; Schott JM; Rossor MN; Crutch SJ; Butler CR; Zeman AZ; Fox NC
    Lancet Neurol; 2018 Feb; 17(2):123-132. PubMed ID: 29413314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual short-term memory binding deficits in familial Alzheimer's disease.
    Parra MA; Abrahams S; Logie RH; Méndez LG; Lopera F; Della Sala S
    Brain; 2010 Sep; 133(9):2702-13. PubMed ID: 20624814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer's disease: a retrospective cohort analysis.
    O'Connor A; Weston PSJ; Pavisic IM; Ryan NS; Collins JD; Lu K; Crutch SJ; Alexander DC; Fox NC; Oxtoby NP
    Alzheimers Res Ther; 2020 Oct; 12(1):126. PubMed ID: 33023653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual short-term memory binding deficit in familial Alzheimer's disease.
    Liang Y; Pertzov Y; Nicholas JM; Henley SMD; Crutch S; Woodward F; Leung K; Fox NC; Husain M
    Cortex; 2016 May; 78():150-164. PubMed ID: 27085491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.
    Pietto M; Parra MA; Trujillo N; Flores F; García AM; Bustin J; Richly P; Manes F; Lopera F; Ibáñez A; Baez S
    J Alzheimers Dis; 2016 Jun; 53(4):1325-40. PubMed ID: 27372640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific deficit of colour-colour short-term memory binding in sporadic and familial Alzheimer's disease.
    Parra MA; Sala SD; Abrahams S; Logie RH; Méndez LG; Lopera F
    Neuropsychologia; 2011 Jun; 49(7):1943-52. PubMed ID: 21435348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The earliest cognitive change in a person with familial Alzheimer's disease: presymptomatic neuropsychological features in a pedigree with familial Alzheimer's disease confirmed at necropsy.
    Newman SK; Warrington EK; Kennedy AM; Rossor MN
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):967-72. PubMed ID: 8057122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Working memory binding and episodic memory formation in aging, mild cognitive impairment, and Alzheimer's dementia.
    van Geldorp B; Heringa SM; van den Berg E; Olde Rikkert MG; Biessels GJ; Kessels RP
    J Clin Exp Neuropsychol; 2015; 37(5):538-48. PubMed ID: 26011711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain Information Sharing During Visual Short-Term Memory Binding Yields a Memory Biomarker for Familial Alzheimer's Disease.
    Parra MA; Mikulan E; Trujillo N; Sala SD; Lopera F; Manes F; Starr J; Ibanez A
    Curr Alzheimer Res; 2017; 14(12):1335-1347. PubMed ID: 28641509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Cognitive Decline across Four Decades in Mutation Carriers and Non-carriers in Autosomal-Dominant Alzheimer's Disease.
    Almkvist O; Rodriguez-Vieitez E; Thordardottir S; Amberla K; Axelman K; Basun H; Kinhult-Ståhlbom A; Lilius L; Remes A; Wahlund LO; Viitanen M; Lannfelt L; Graff C
    J Int Neuropsychol Soc; 2017 Mar; 23(3):195-203. PubMed ID: 28079014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory binding and white matter integrity in familial Alzheimer's disease.
    Parra MA; Saarimäki H; Bastin ME; Londoño AC; Pettit L; Lopera F; Della Sala S; Abrahams S
    Brain; 2015 May; 138(Pt 5):1355-69. PubMed ID: 25762465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.
    Fox NC; Warrington EK; Seiffer AL; Agnew SK; Rossor MN
    Brain; 1998 Sep; 121 ( Pt 9)():1631-9. PubMed ID: 9762953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biomarker changes in dominantly inherited Alzheimer's disease.
    Bateman RJ; Xiong C; Benzinger TL; Fagan AM; Goate A; Fox NC; Marcus DS; Cairns NJ; Xie X; Blazey TM; Holtzman DM; Santacruz A; Buckles V; Oliver A; Moulder K; Aisen PS; Ghetti B; Klunk WE; McDade E; Martins RN; Masters CL; Mayeux R; Ringman JM; Rossor MN; Schofield PR; Sperling RA; Salloway S; Morris JC;
    N Engl J Med; 2012 Aug; 367(9):795-804. PubMed ID: 22784036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.
    Fleisher AS; Chen K; Quiroz YT; Jakimovich LJ; Gomez MG; Langois CM; Langbaum JB; Ayutyanont N; Roontiva A; Thiyyagura P; Lee W; Mo H; Lopez L; Moreno S; Acosta-Baena N; Giraldo M; Garcia G; Reiman RA; Huentelman MJ; Kosik KS; Tariot PN; Lopera F; Reiman EM
    Lancet Neurol; 2012 Dec; 11(12):1057-65. PubMed ID: 23137949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Rodriguez-Vieitez E; Saint-Aubert L; Carter SF; Almkvist O; Farid K; Schöll M; Chiotis K; Thordardottir S; Graff C; Wall A; Långström B; Nordberg A
    Brain; 2016 Mar; 139(Pt 3):922-36. PubMed ID: 26813969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of patients with questionable (very mild) Alzheimer's disease: longitudinal profiles of individual subjects' decline.
    Perry RJ; Hodges JR
    Dement Geriatr Cogn Disord; 2000; 11(6):342-9. PubMed ID: 11044780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.